The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concerns

Archive ouverte

Amini-Adle, M. | Arnault, J.-P. | Aubin, F. | Beneton, N. | Bens, G. | Brunet-Possenti, F. | Célerier, P. | Charles, J. | Crumbach, L. | Dalac, S. | Darras, S. | de Quatrebarbes, J. | Dinulescu, M. | Dutriaux, C. | Gaudy, C. | Gérard, E. | Giacchero, D. | Granel-Brocard, F. | Grange, F. | Jouary, T. | Kramkimel, N. | Lebbé, C. | Le Corre, Y. | Legoupil, D. | Lesage, C. | Lesimple, T. | Lorphelin, J.-M. | Mansard, S. | Martin, L. | Mary-Prey, S. | Maubec, E. | Meyer, N. | Mignard, C. | Montaudie, H. | Mortier, L. | Nardin, C. | Neidhardt Berard, E.-M. | Pagès Laurent, C. | Peuvrel, L. | Quereux, Gaelle | Robert, Caroline | Saiag, Philippe | Saint-Jean, Mélanie | Samimi, M. | Sassolas, B. | Scalbert, C. | Skowron, F. | Steff, M. | Stoebner, P.-E. | Trablesi, S. | Visseaux, L. | Zehou, O. | Boespflug, A.

Edité par CCSD ; Elsevier Masson -

International audience

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion